Cover Image
Market Research Report
Product code 
1031626

Breast Biopsy Market Research Report by Product, by Type, by Guidance, by Application, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

Published: | 360iResearch LLP | 199 Pages | Delivery time: 1-2 business days

Price

Back to Top
Breast Biopsy Market Research Report by Product, by Type, by Guidance, by Application, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
Published: October 5, 2021
360iResearch LLP
Content info: 199 Pages
Delivery time: 1-2 business days
  • ALL
  • Description
  • Table of Contents
Description

The Global Breast Biopsy Market size was estimated at USD 763.43 million in 2020 and expected to reach USD 835.85 million in 2021, at a CAGR 9.82% to reach USD 1,339.56 million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Breast Biopsy to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the market was studied across Assay Kits, Biopsy Needles, Biopsy Tables, Guidance Systems, Liquid Biopsy Instruments, and Localization Wires.

Based on Type, the market was studied across Liquid Breast Biopsy, Needle Breast Biopsy, and Open Surgical Breast Biopsy. The Liquid Breast Biopsy is further studied across Circulating Tumor Cells and Circulating Tumor DNA. The Needle Breast Biopsy is further studied across Core Needle Biopsy, Fine Needle Aspiration Biopsy, and Vacuum-Assisted Biopsy. The Open Surgical Breast Biopsy is further studied across Excisional and Incisional.

Based on Guidance, the market was studied across Image-Guided Biopsy and Liquid Biopsy. The Image-Guided Biopsy is further studied across Mammography-Guided Stereotactic Biopsy, MRI Guided Biopsy, and Ultrasound-Guided Biopsy. The Liquid Biopsy is further studied across Microarray-Based Biopsy, NGS-Based Biopsy, and PCR-Based Biopsy.

Based on Application, the market was studied across Early Cancer Screening, Recurrence Monitoring, Therapy Selection, and Treatment Monitoring.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Breast Biopsy Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Breast Biopsy Market, including Argon Medical Devices, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biocept, Inc., Cardiff Oncology, Inc., Cook Medical Incorporated, Danaher Corporation, Encapsule Medical Devices, LLC, Ethicon Endo-Surgery, EXACT Sciences Corporation, F. Hoffmann-La Roche AG, Fluxion Biosciences, Inc., Gallini S.r.l., Hologic, Inc., Illumina, Inc., IZI Medical Products, LLC, Leica Biosystems Nussloch GmbH, Medtronic PLC, Menarini Silicon Biosystems, S.p.A., Merit Medical Systems, Inc., Myriad Genetics, Inc., QIAGEN, Scion Medical Technologies, LLC, STERYLAB S.r.l., and Thermo Fisher Scientific.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Breast Biopsy Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Breast Biopsy Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Breast Biopsy Market?
  • 4. What is the competitive strategic window for opportunities in the Global Breast Biopsy Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Breast Biopsy Market?
  • 6. What is the market share of the leading vendors in the Global Breast Biopsy Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Breast Biopsy Market?
Table of Contents
Product Code: MRR-4F4C36263249

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction

4. Market Overview

  • 4.1. Introduction
  • 4.2. Cumulative Impact of COVID-19

5. Market Dynamics

  • 5.1. Introduction
  • 5.2. Drivers
    • 5.2.1. Rising concerns of breast cancer screening programs
    • 5.2.2. Growing awareness regarding early detection of breast cancer
  • 5.3. Restraints
    • 5.3.1. Infectious risk associated with breast biopsy procedures
    • 5.3.2. Stringent regulatory approval policies
  • 5.4. Opportunities
    • 5.4.1. Emergence of liquid biopsy and promising clinical trials
    • 5.4.2. Increasing investments and funding for R&D of cancer treatment
  • 5.5. Challenges
    • 5.5.1. Dearth of skilled persons and costly treatment
    • 5.5.2. Lack of advance infrastructure in developing countries

6. Breast Biopsy Market, by Product

  • 6.1. Introduction
  • 6.2. Assay Kits
  • 6.3. Biopsy Needles
  • 6.4. Biopsy Tables
  • 6.5. Guidance Systems
  • 6.6. Liquid Biopsy Instruments
  • 6.7. Localization Wires

7. Breast Biopsy Market, by Type

  • 7.1. Introduction
  • 7.2. Liquid Breast Biopsy
    • 7.2.1. Circulating Tumor Cells
    • 7.2.2. Circulating Tumor DNA
  • 7.3. Needle Breast Biopsy
    • 7.3.1. Core Needle Biopsy
    • 7.3.2. Fine Needle Aspiration Biopsy
    • 7.3.3. Vacuum-Assisted Biopsy
  • 7.4. Open Surgical Breast Biopsy
    • 7.4.1. Excisional
    • 7.4.2. Incisional

8. Breast Biopsy Market, by Guidance

  • 8.1. Introduction
  • 8.2. Image-Guided Biopsy
    • 8.2.1. Mammography-Guided Stereotactic Biopsy
    • 8.2.2. MRI Guided Biopsy
    • 8.2.3. Ultrasound-Guided Biopsy
  • 8.3. Liquid Biopsy
    • 8.3.1. Microarray-Based Biopsy
    • 8.3.2. NGS-Based Biopsy
    • 8.3.3. PCR-Based Biopsy

9. Breast Biopsy Market, by Application

  • 9.1. Introduction
  • 9.2. Early Cancer Screening
  • 9.3. Recurrence Monitoring
  • 9.4. Therapy Selection
  • 9.5. Treatment Monitoring

10. Americas Breast Biopsy Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Breast Biopsy Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand

12. Europe, Middle East & Africa Breast Biopsy Market

  • 12.1. Introduction
  • 12.2. France
  • 12.3. Germany
  • 12.4. Italy
  • 12.5. Netherlands
  • 12.6. Qatar
  • 12.7. Russia
  • 12.8. Saudi Arabia
  • 12.9. South Africa
  • 12.10. Spain
  • 12.11. United Arab Emirates
  • 12.12. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
    • 13.1.1. Quadrants
    • 13.1.2. Business Strategy
    • 13.1.3. Product Satisfaction
  • 13.2. Market Ranking Analysis
  • 13.3. Market Share Analysis, By Key Player
  • 13.4. Competitive Scenario
    • 13.4.1. Merger & Acquisition
    • 13.4.2. Agreement, Collaboration, & Partnership
    • 13.4.3. New Product Launch & Enhancement
    • 13.4.4. Investment & Funding
    • 13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles

  • 14.1. Argon Medical Devices, Inc.
  • 14.2. Becton, Dickinson and Company
  • 14.3. Bio-Rad Laboratories, Inc.
  • 14.4. Biocept, Inc.
  • 14.5. Cardiff Oncology, Inc.
  • 14.6. Cook Medical Incorporated
  • 14.7. Danaher Corporation
  • 14.8. Encapsule Medical Devices, LLC
  • 14.9. Ethicon Endo-Surgery
  • 14.10. EXACT Sciences Corporation
  • 14.11. F. Hoffmann-La Roche AG
  • 14.12. Fluxion Biosciences, Inc.
  • 14.13. Gallini S.r.l.
  • 14.14. Hologic, Inc.
  • 14.15. Illumina, Inc.
  • 14.16. IZI Medical Products, LLC
  • 14.17. Leica Biosystems Nussloch GmbH
  • 14.18. Medtronic PLC
  • 14.19. Menarini Silicon Biosystems, S.p.A.
  • 14.20. Merit Medical Systems, Inc.
  • 14.21. Myriad Genetics, Inc.
  • 14.22. QIAGEN
  • 14.23. Scion Medical Technologies, LLC
  • 14.24. STERYLAB S.r.l.
  • 14.25. Thermo Fisher Scientific

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. GLOBAL BREAST BIOPSY MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 3. GLOBAL BREAST BIOPSY MARKET: MARKET DYNAMICS
  • FIGURE 4. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
  • FIGURE 5. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD MILLION)
  • FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2026
  • FIGURE 7. GLOBAL BREAST BIOPSY MARKET SIZE, BY ASSAY KITS, 2018-2026 (USD MILLION)
  • FIGURE 8. GLOBAL BREAST BIOPSY MARKET SIZE, BY ASSAY KITS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 9. GLOBAL BREAST BIOPSY MARKET SIZE, BY BIOPSY NEEDLES, 2018-2026 (USD MILLION)
  • FIGURE 10. GLOBAL BREAST BIOPSY MARKET SIZE, BY BIOPSY NEEDLES, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 11. GLOBAL BREAST BIOPSY MARKET SIZE, BY BIOPSY TABLES, 2018-2026 (USD MILLION)
  • FIGURE 12. GLOBAL BREAST BIOPSY MARKET SIZE, BY BIOPSY TABLES, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 13. GLOBAL BREAST BIOPSY MARKET SIZE, BY GUIDANCE SYSTEMS, 2018-2026 (USD MILLION)
  • FIGURE 14. GLOBAL BREAST BIOPSY MARKET SIZE, BY GUIDANCE SYSTEMS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 15. GLOBAL BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY INSTRUMENTS, 2018-2026 (USD MILLION)
  • FIGURE 16. GLOBAL BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY INSTRUMENTS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 17. GLOBAL BREAST BIOPSY MARKET SIZE, BY LOCALIZATION WIRES, 2018-2026 (USD MILLION)
  • FIGURE 18. GLOBAL BREAST BIOPSY MARKET SIZE, BY LOCALIZATION WIRES, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 19. GLOBAL BREAST BIOPSY MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
  • FIGURE 20. GLOBAL BREAST BIOPSY MARKET SIZE, BY TYPE, 2020 VS 2026 (USD MILLION)
  • FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BREAST BIOPSY MARKET SIZE, BY TYPE, 2026
  • FIGURE 22. GLOBAL BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2026 (USD MILLION)
  • FIGURE 23. GLOBAL BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 24. GLOBAL BREAST BIOPSY MARKET SIZE, BY CIRCULATING TUMOR CELLS, 2018-2026 (USD MILLION)
  • FIGURE 25. GLOBAL BREAST BIOPSY MARKET SIZE, BY CIRCULATING TUMOR CELLS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 26. GLOBAL BREAST BIOPSY MARKET SIZE, BY CIRCULATING TUMOR DNA, 2018-2026 (USD MILLION)
  • FIGURE 27. GLOBAL BREAST BIOPSY MARKET SIZE, BY CIRCULATING TUMOR DNA, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 28. GLOBAL BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2026 (USD MILLION)
  • FIGURE 29. GLOBAL BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 30. GLOBAL BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY, 2018-2026 (USD MILLION)
  • FIGURE 31. GLOBAL BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 32. GLOBAL BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION BIOPSY, 2018-2026 (USD MILLION)
  • FIGURE 33. GLOBAL BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION BIOPSY, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 34. GLOBAL BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED BIOPSY, 2018-2026 (USD MILLION)
  • FIGURE 35. GLOBAL BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED BIOPSY, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 36. GLOBAL BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2026 (USD MILLION)
  • FIGURE 37. GLOBAL BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 38. GLOBAL BREAST BIOPSY MARKET SIZE, BY EXCISIONAL, 2018-2026 (USD MILLION)
  • FIGURE 39. GLOBAL BREAST BIOPSY MARKET SIZE, BY EXCISIONAL, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 40. GLOBAL BREAST BIOPSY MARKET SIZE, BY INCISIONAL, 2018-2026 (USD MILLION)
  • FIGURE 41. GLOBAL BREAST BIOPSY MARKET SIZE, BY INCISIONAL, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 42. GLOBAL BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2020 VS 2026 (%)
  • FIGURE 43. GLOBAL BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2020 VS 2026 (USD MILLION)
  • FIGURE 44. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2026
  • FIGURE 45. GLOBAL BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2026 (USD MILLION)
  • FIGURE 46. GLOBAL BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 47. GLOBAL BREAST BIOPSY MARKET SIZE, BY MAMMOGRAPHY-GUIDED STEREOTACTIC BIOPSY, 2018-2026 (USD MILLION)
  • FIGURE 48. GLOBAL BREAST BIOPSY MARKET SIZE, BY MAMMOGRAPHY-GUIDED STEREOTACTIC BIOPSY, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 49. GLOBAL BREAST BIOPSY MARKET SIZE, BY MRI GUIDED BIOPSY, 2018-2026 (USD MILLION)
  • FIGURE 50. GLOBAL BREAST BIOPSY MARKET SIZE, BY MRI GUIDED BIOPSY, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 51. GLOBAL BREAST BIOPSY MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2026 (USD MILLION)
  • FIGURE 52. GLOBAL BREAST BIOPSY MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 53. GLOBAL BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2026 (USD MILLION)
  • FIGURE 54. GLOBAL BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 55. GLOBAL BREAST BIOPSY MARKET SIZE, BY MICROARRAY-BASED BIOPSY, 2018-2026 (USD MILLION)
  • FIGURE 56. GLOBAL BREAST BIOPSY MARKET SIZE, BY MICROARRAY-BASED BIOPSY, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 57. GLOBAL BREAST BIOPSY MARKET SIZE, BY NGS-BASED BIOPSY, 2018-2026 (USD MILLION)
  • FIGURE 58. GLOBAL BREAST BIOPSY MARKET SIZE, BY NGS-BASED BIOPSY, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 59. GLOBAL BREAST BIOPSY MARKET SIZE, BY PCR-BASED BIOPSY, 2018-2026 (USD MILLION)
  • FIGURE 60. GLOBAL BREAST BIOPSY MARKET SIZE, BY PCR-BASED BIOPSY, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 61. GLOBAL BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
  • FIGURE 62. GLOBAL BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
  • FIGURE 63. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2026
  • FIGURE 64. GLOBAL BREAST BIOPSY MARKET SIZE, BY EARLY CANCER SCREENING, 2018-2026 (USD MILLION)
  • FIGURE 65. GLOBAL BREAST BIOPSY MARKET SIZE, BY EARLY CANCER SCREENING, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 66. GLOBAL BREAST BIOPSY MARKET SIZE, BY RECURRENCE MONITORING, 2018-2026 (USD MILLION)
  • FIGURE 67. GLOBAL BREAST BIOPSY MARKET SIZE, BY RECURRENCE MONITORING, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 68. GLOBAL BREAST BIOPSY MARKET SIZE, BY THERAPY SELECTION, 2018-2026 (USD MILLION)
  • FIGURE 69. GLOBAL BREAST BIOPSY MARKET SIZE, BY THERAPY SELECTION, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 70. GLOBAL BREAST BIOPSY MARKET SIZE, BY TREATMENT MONITORING, 2018-2026 (USD MILLION)
  • FIGURE 71. GLOBAL BREAST BIOPSY MARKET SIZE, BY TREATMENT MONITORING, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 72. AMERICAS BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 73. ARGENTINA BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 74. BRAZIL BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 75. CANADA BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 76. MEXICO BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 77. UNITED STATES BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 78. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 79. AUSTRALIA BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 80. CHINA BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 81. INDIA BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 82. INDONESIA BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 83. JAPAN BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 84. MALAYSIA BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 85. PHILIPPINES BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 86. SINGAPORE BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 87. SOUTH KOREA BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 88. TAIWAN BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 89. THAILAND BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 90. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 91. FRANCE BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 92. GERMANY BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 93. ITALY BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 94. NETHERLANDS BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 95. QATAR BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 96. RUSSIA BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 97. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 98. SOUTH AFRICA BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 99. SPAIN BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 100. UNITED ARAB EMIRATES BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 101. UNITED KINGDOM BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 102. GLOBAL BREAST BIOPSY MARKET: FPNV POSITIONING MATRIX
  • FIGURE 103. GLOBAL BREAST BIOPSY MARKET: SHARE, BY KEY PLAYER, 2020
  • FIGURE 104. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL BREAST BIOPSY MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL BREAST BIOPSY MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 4. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
  • TABLE 5. GLOBAL BREAST BIOPSY MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 6. GLOBAL BREAST BIOPSY MARKET SIZE, BY BIOPSY NEEDLES, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 7. GLOBAL BREAST BIOPSY MARKET SIZE, BY BIOPSY TABLES, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 8. GLOBAL BREAST BIOPSY MARKET SIZE, BY GUIDANCE SYSTEMS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 9. GLOBAL BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY INSTRUMENTS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 10. GLOBAL BREAST BIOPSY MARKET SIZE, BY LOCALIZATION WIRES, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 11. GLOBAL BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
  • TABLE 12. GLOBAL BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 13. GLOBAL BREAST BIOPSY MARKET SIZE, BY CIRCULATING TUMOR CELLS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 14. GLOBAL BREAST BIOPSY MARKET SIZE, BY CIRCULATING TUMOR DNA, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 15. GLOBAL BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 16. GLOBAL BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 17. GLOBAL BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION BIOPSY, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 18. GLOBAL BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED BIOPSY, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 19. GLOBAL BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 20. GLOBAL BREAST BIOPSY MARKET SIZE, BY EXCISIONAL, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 21. GLOBAL BREAST BIOPSY MARKET SIZE, BY INCISIONAL, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 22. GLOBAL BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2026 (USD MILLION)
  • TABLE 23. GLOBAL BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 24. GLOBAL BREAST BIOPSY MARKET SIZE, BY MAMMOGRAPHY-GUIDED STEREOTACTIC BIOPSY, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 25. GLOBAL BREAST BIOPSY MARKET SIZE, BY MRI GUIDED BIOPSY, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 26. GLOBAL BREAST BIOPSY MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 27. GLOBAL BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 28. GLOBAL BREAST BIOPSY MARKET SIZE, BY MICROARRAY-BASED BIOPSY, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 29. GLOBAL BREAST BIOPSY MARKET SIZE, BY NGS-BASED BIOPSY, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 30. GLOBAL BREAST BIOPSY MARKET SIZE, BY PCR-BASED BIOPSY, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 31. GLOBAL BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
  • TABLE 32. GLOBAL BREAST BIOPSY MARKET SIZE, BY EARLY CANCER SCREENING, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 33. GLOBAL BREAST BIOPSY MARKET SIZE, BY RECURRENCE MONITORING, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 34. GLOBAL BREAST BIOPSY MARKET SIZE, BY THERAPY SELECTION, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 35. GLOBAL BREAST BIOPSY MARKET SIZE, BY TREATMENT MONITORING, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 36. AMERICAS BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 37. ARGENTINA BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 38. BRAZIL BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 39. CANADA BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 40. MEXICO BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 41. UNITED STATES BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 43. AUSTRALIA BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 44. CHINA BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 45. INDIA BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 46. INDONESIA BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 47. JAPAN BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 48. MALAYSIA BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 49. PHILIPPINES BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 50. SINGAPORE BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 51. SOUTH KOREA BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 52. TAIWAN BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 53. THAILAND BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 55. FRANCE BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 56. GERMANY BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 57. ITALY BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 58. NETHERLANDS BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 59. QATAR BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 60. RUSSIA BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 61. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 62. SOUTH AFRICA BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 63. SPAIN BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 64. UNITED ARAB EMIRATES BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 65. UNITED KINGDOM BREAST BIOPSY MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 66. GLOBAL BREAST BIOPSY MARKET: SCORES
  • TABLE 67. GLOBAL BREAST BIOPSY MARKET: BUSINESS STRATEGY
  • TABLE 68. GLOBAL BREAST BIOPSY MARKET: PRODUCT SATISFACTION
  • TABLE 69. GLOBAL BREAST BIOPSY MARKET: RANKING
  • TABLE 70. GLOBAL BREAST BIOPSY MARKET: SHARE, BY KEY PLAYER, 2020
  • TABLE 71. GLOBAL BREAST BIOPSY MARKET: MERGER & ACQUISITION
  • TABLE 72. GLOBAL BREAST BIOPSY MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 73. GLOBAL BREAST BIOPSY MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 74. GLOBAL BREAST BIOPSY MARKET: INVESTMENT & FUNDING
  • TABLE 75. GLOBAL BREAST BIOPSY MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 76. GLOBAL BREAST BIOPSY MARKET: LICENSE & PRICING